Company: LENZ
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001628280-25-016815
Chunk: 28

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-04
Form: POS AM
Chunk 28
---
 No. 1 to the Company’s Registration Statement on Form S-1 filed with the SEC on June 11, 2021).                                                                                            |
| 4.2     |     | Form of Warrant to Purchase Shares of Series A Preferred Stock (incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-4 filed with the SEC on December 6, 2023).                                                                               |
| 5.1     |     | Opinion of Wilson Sonsini Goodrich & Rosati, P.C. (incorporated by reference to Exhibit 5.1 to the Company’s Registration Statement on Form S-1 (File No. 333-282036) filed with the SEC on September 11, 2024.                                                                     |
| 10.1    |     | Stock Purchase Agreement, dated July 14, 2024, by and among LENZ Therapeutics, Inc. and certain parties thereto (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 14, 2024).                                   |
| 23.1    |     | Consent of Independent Registered Public Accounting Firm.                                                                                                                                                                                                                           |
| 23.2    |     | Consent of Wilson Sonsini Goodrich & Rosati, P.C. (included in Exhibit 5.1).                                                                                                                                                                                                        |
| 24.1    |     | Power of Attorney (included on signature page to the Company’s Registration Statement on Form S-1 (File No. 333-282036) filed with the SEC on September 11, 2024.                                                                                                                   |

__________________

† Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

(2)

#### Financial Statement Schedules
. All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated financial statements or in the notes thereto.

<div align='center'>II-2</div>

## ITEM 17. UNDERTAKINGS.
(1) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(1) To include any prospectus required by section 10(a)(3) of the Securities Act